System and method related to enhancing an immune system
First Claim
Patent Images
1. A method of enhancing an immune response, comprising:
- presenting one or more determinants of an agent;
providing a predicted pattern for a progression related to the one or more determinants of the agent; and
designating the selection of at least one immune response component corresponding to the one or more determinants of the agent.
1 Assignment
0 Petitions
Accused Products
Abstract
The present application relates, in general, to a system and/or method related to detection and/or treatment.
23 Citations
129 Claims
-
1. A method of enhancing an immune response, comprising:
-
presenting one or more determinants of an agent;
providing a predicted pattern for a progression related to the one or more determinants of the agent; and
designating the selection of at least one immune response component corresponding to the one or more determinants of the agent. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61)
-
2. The method of claim 1, wherein the presenting one or more determinants of an agent further comprises:
presenting the one or more determinants of the agent associated with eliciting at least a part of at least one of an immune response or a progression of an immune response.
-
3. The method of claim 1, wherein the one or more determinants of an agent further comprises:
at least a part of at least one of an amino acid residue, a nucleotide, a carbohydrate, a protein, a lipid, a capsid protein, a polysaccharide, a lipopolysaccharide, a glycolipid, or a glycoprotein.
-
4. The method of claim 1, wherein the one or more determinants of an agent further comprises:
a substantially linear form.
-
5. The method of claim 1, wherein the one or more determinants of an agent further comprises:
a substantially non-linear form.
-
6. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent in response to an input.
-
7. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent in response to a user input.
-
8. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent in response to a robotic input.
-
9. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
associating the one or more determinants of the agent with a predicted pattern for a progression of at least a part of an immune response in a host.
-
10. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
predicting one or more pattern changes in the one or more determinants of the agent.
-
11. The method of claim 10, wherein the predicting one or more pattern changes in the one or more determinants of the agent further comprises:
correlating the one or more pattern changes in the one or more determinants of the agent to one or more progressions of an elicited immune response.
-
12. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant with up to about 80% amino acid sequence match with an entity.
-
13. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant with up to about 70% amino acid sequence match with an entity.
-
14. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant with up to about 60% amino acid sequence match with an entity.
-
15. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of an agent wherein the set or subset has at least one determinant having between 0% to about 80% sequence match with an entity.
-
16. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a likely sequence match with an entity.
-
17. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having between 0 to 100% sequence match with an entity.
-
18. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having at least 88% sequence match with an entity.
-
19. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having at least 75% sequence match with an entity.
-
20. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar functional sequence match with an entity.
-
21. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar structural match with an entity.
-
22. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar effect on the immune response.
-
23. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar functional effect.
-
24. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar result in an assay.
-
25. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one substantially antigenic determinant.
-
26. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one immunologically effective determinant.
-
27. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of an agent wherein the set or subset includes at least one determinant displayed by the agent.
-
28. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset represents at least one determinant having a copy number of at least two and displayed by the agent.
-
29. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset represents at least one determinant having a copy number of at least two and that is recognized.
-
30. The method of claim 1, wherein the providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
forming a set or subset of the one or more determinants of the agent wherein the set or subset represents at least one determinant bound by the agent.
-
31. The method of claim 1, wherein the presenting one or more determinants of an agent further comprises:
including data from databases for influencing the selection of the one or more determinants of the agent.
-
32. The method of claim 31, wherein the including data from databases for influencing the selection of the one or more determinants of the agent further comprises:
including data from at least one of a plant database, an animal database, a bacterium database, a viral database, a biological database, a genetic database, a genomic database, a structural database, a SNP database, or an immunological database.
-
33. The method of claim 31, wherein the including data from databases for influencing the selection of the one or more determinants of the agent further comprises:
including data from a human database.
-
34. The method of claim 31, wherein the including data from databases for influencing the selection of the one or more determinants of the agent further comprises:
including data from a pathogen database.
-
35. The method of claim 1, wherein the presenting one or more determinants of an agent further comprises:
influencing the presentation of the one or more determinants of the agent by including information from one or more databases having information related to a restriction fragment length polymorphism, a microsatellite marker, a short tandem repeat, a random amplified polymorphic DNA, an amplified fragment length polymorphism, or a sequence repeat.
-
36. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of at least one of the immune response component by including data from at least one of a plant database, an animal database, a bacterium database, a viral database, a biological database, a genetic database, a genomic database, a structural database, a SNP database, or an immunological database.
-
37. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
including data from a human database.
-
38. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
including data from a pathogen database.
-
39. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of at least one of the immune response component associated with the at least one determinant of the agent operable for modulating at least a part of the immune response.
-
40. The method of claim 1, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least a part of one or more of a macrophage, a lymphocyte, a T-lymphocyte, a killer T-lymphocyte, an immune response modulator, a helper T-lymphocyte, an antigen receptor, an antigen presenting cell, a cytotoxic T-lymphocyte, a T-8 lymphocyte, a cluster differentiation (CD) molecule, a CD3 molecule, or a CD1 molecule.
-
41. The method of claim 1, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least a part of at least one of a B-lymphocyte.
-
42. The method of claim 1, wherein the immune response component corresponding to the one or more determinants of the agent further comprises:
at least one of a modulator of at least a part of a B-lymphocyte.
-
43. The method of claim 1, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least one modulator of at least a part of at least one of a macrophage, lymphocyte, a T-lymphocyte, a killer T-lymphocyte, an immune response modulator, a helper T-lymphocyte, an antigen receptor, an antigen presenting cell, a cytotoxic T-lymphocyte, a T-8 lymphocyte, a cluster differentiation (CD) molecule, a CD3 molecule, or a CD1 molecule.
-
44. The method of claim 1, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a chimeric antibody, a humanized antibody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.
-
45. The method of claim 1, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least one modulator of at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a chimeric antibody, a humanized antibody, a human antibody, a heteroantibody, a monoclonal antibody, polyclonal antibody, or an antibody fragment.
-
46. The method of claim 1, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least a part of at least one of a synthetic antibody or a modulator of a synthetic antibody.
-
47. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of the at least one immune response component by directing the formation of one or more human or humanized antibodies associated with the one or more determinants of the agent operable for modulating at least a part of the immune response.
-
48. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of the at least one immune response component by directing the formation of one or more chimeric antibodies associated with the one or more determinants of the agent operable for modulating at least a part of the immune response.
-
49. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of the at least one immune response component by directing the formation of one or more recombinant antibodies associated with the one or more determinants of the agent operable for modulating at least a part of the immune response.
-
50. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of the at least one immune response component by including data from databases for influencing the identification of the one or more determinants of the agent.
-
51. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of the at least one immune response component by including data from genomic, immunological, biological, or SNP databases for influencing the identification of at least one determinant of the agent.
-
52. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of the at least one immune response component by including data from a pathogen database.
-
53. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
designating the selection of the at least one immune response component by including data from a human database.
-
54. The method of claim 1, wherein the designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
aiding the selection of the at least one immune response component by providing a plan.
-
55. The method of claim 54, wherein the aiding the selection of the at least one immune response component by providing a plan further comprises:
providing the plan for managing at least a part of the immune response.
-
56. The method of claim 54, wherein the plan further comprises:
at least one of a dosage, a dosing pattern, an effective route, or duration of a dosage.
-
57. The method of claim 56, wherein the effective route comprises:
at least one of a sub-cutaneous route, a nasal route, an intranasal route, an intramuscular route, an intravenous route, an intraarterial route, an intrathecal route, an intracapsular route, an intraorbital route, an intracardiac route, a transdermal route, an intradermal route, an intraperitoneal route, a transtracheal route, a subcuticular route, an intraarticular route, a subcapsular route, a subarachnoidal route, an intraspinal route, an epidural route, an intrastemal route, an infusion route, a topical route, a sublingual route, or an enteric route.
-
58. The method of claim 1, wherein the presenting one or more determinants of an agent further comprises:
presenting one or more determinants associated with a response and wherein the response requires management.
-
59. The method of claim 1, wherein the presenting one or more determinants of an agent further comprises:
presenting at least a portion of at least one of a virus, a bacterium, a yeast, a mold, a fungus, a mycoplasma, a ureaplasma, a Chlamydia, a rickettsia, a nanobacterium, a prion, an agent responsible for TSE, a multicellular parasite, a protein, an infectious protein, a nucleic acid, a metabolic by-product, a cellular by-product, or a toxin.
-
60. The method of claim 1, wherein the agent includes:
at least a portion of a living agent.
-
61. The method of claim 1, wherein the agent includes:
at least a portion of a non-living agent.
-
2. The method of claim 1, wherein the presenting one or more determinants of an agent further comprises:
-
-
62. A system, comprising:
-
circuitry for presenting one or more determinants of an agent;
circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent; and
circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent. - View Dependent Claims (63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122)
-
63. The system of claim 62, wherein the circuitry for presenting one or more determinants of an agent further comprises:
circuitry for presenting the one or more determinants of the agent associated with eliciting at least a part of at least one of an immune response or a progression of an immune response.
-
64. The system of claim 62, wherein the one or more determinants of an agent further comprises:
at least a part of at least one of an amino acid residue, a nucleotide, a carbohydrate, a protein, a lipid, a capsid protein, a polysaccharide, a lipopolysaccharide, a glycolipid, or a glycoprotein.
-
65. The system of claim 62, wherein the one or more determinants of an agent further comprises:
a substantially linear form.
-
66. The system of claim 62, wherein the one or more determinants of an agent further comprises:
a substantially non-linear form.
-
67. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent in response to an input.
-
68. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent in response to a user input.
-
69. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent in response to a robotic input.
-
70. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for associating the one or more determinants of the agent with a predicted pattern for a progression of at least a part of an immune response in a host.
-
71. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for predicting one or more pattern changes in the one or more determinants of the agent.
-
72. The system of claim 71, wherein the circuitry for predicting one or more pattern changes in the one or more determinants of the agent further comprises:
circuitry for correlating the one or more pattern changes in the one or more determinants of the agent to one or more progressions of an elicited immune response.
-
73. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant with up to about 80% amino acid sequence match with an entity.
-
74. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant with up to about 70% amino acid sequence match with an entity.
-
75. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant with up to about 60% amino acid sequence match with an entity.
-
76. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of an agent wherein the set or subset has at least one determinant having between 0% to about 80% sequence match with an entity.
-
77. The system of claim 76, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a likely sequence match with an entity.
-
78. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having between 0 to 100% sequence match with an entity.
-
79. The system of claim 78, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having at least 88% sequence match with an entity.
-
80. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having at least 75% sequence match with an entity.
-
81. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar functional sequence match with an entity.
-
82. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar structural match with an entity.
-
83. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar effect on the immune response.
-
84. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar functional effect.
-
85. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one determinant having a substantially similar result in an assay.
-
86. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one substantially antigenic determinant.
-
87. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset includes at least one immunologically effective determinant.
-
88. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of an agent wherein the set or subset includes at least one determinant displayed by the agent.
-
89. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset represents at least one determinant having a copy number of at least two and displayed by the agent.
-
90. The system of claim 62, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset represents at least one determinant having a copy number of at least two and that is recognized.
-
91. The system of claim 90, wherein the circuitry for providing a predicted pattern for a progression related to the one or more determinants of the agent further comprises:
circuitry for forming a set or subset of the one or more determinants of the agent wherein the set or subset represents at least one determinant bound by the agent.
-
92. The system of claim 62, wherein the circuitry for presenting one or more determinants of an agent further comprises:
circuitry for including data from databases for influencing the selection of the one or more determinants of the agent.
-
93. The system of claim 92, wherein the circuitry for including data from databases for influencing the selection of the one or more determinants of the agent further comprises:
circuitry for including data from at least one of a plant database, an animal database, a bacterium database, a viral database, a biological database, a genetic database, a genomic database, a structural database, a SNP database, or an immunological database.
-
94. The system of claim 92, wherein the circuitry for including data from databases for influencing the selection of the one or more determinants of the agent further comprises:
circuitry for including data from a human database.
-
95. The system of claim 92, wherein the circuitry for including data from databases for influencing the selection of the one or more determinants of the agent further comprises:
circuitry for including data from a pathogen database.
-
96. The system of claim 95, wherein the circuitry for presenting one or more determinants of an agent further comprises:
circuitry for influencing the presentation of the one or more determinants of the agent by including information from one or more databases having information related to a restriction fragment length polymorphism, a microsatellite marker, a short tandem repeat, a random amplified polymorphic DNA, an amplified fragment length polymorphism, or a sequence repeat.
-
97. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of at least one of the immune response component by including data from at least one of a plant database, an animal database, a bacterium database, a viral database, a biological database, a genetic database, a genomic database, a structural database, a SNP database, or an immunological database.
-
98. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for including data from a human database.
-
99. The system of claim 98, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for including data from a pathogen database.
-
100. The system of claim 98, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of at least one of the immune response component associated with the at least one determinant of the agent operable for modulating at least a part of the immune response.
-
101. The system of claim 98, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
-
at least a part of one or more of a macrophage, a lymphocyte, a T-lymphocyte, a killer T-lymphocyte, an immune response modulator, a helper T-lymphocyte, an antigen receptor, an antigen presenting cell, a cytotoxic T-lymphocyte, a T-8 lymphocyte, a cluster differentiation (CD) molecule, a CD3 molecule, or a CD 1 molecule.
-
-
102. The system of claim 62, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least a part of at least one of a B-lymphocyte.
-
103. The system of claim 62, wherein the immune response component corresponding to the one or more determinants of the agent further comprises:
at least one of a modulator of at least a part of a B-lymphocyte.
-
104. The system of claim 62, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least one modulator of at least a part of at least one of a macrophage, lymphocyte, a T-lymphocyte, a killer T-lymphocyte, an immune response modulator, a helper T-lymphocyte, an antigen receptor, an antigen presenting cell, a cytotoxic T-lymphocyte, a T-8 lymphocyte, a cluster differentiation (CD) molecule, a CD3 molecule, or a CD1 molecule.
-
105. The system of claim 62, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a chimeric antibody, a humanized antibody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.
-
106. The system of claim 62, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least one modulator of at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a chimeric antibody, a humanized antibody, a human antibody, a heteroantibody, a monoclonal antibody, polyclonal antibody, or an antibody fragment.
-
107. The system of claim 62, wherein the at least one immune response component corresponding to the one or more determinants of the agent further comprises:
at least a part of at least one of a synthetic antibody or a modulator of a synthetic antibody.
-
108. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of the at least one immune response component by directing the formation of one or more human or humanized antibodies associated with the one or more determinants of the agent operable for modulating at least a part of the immune response.
-
109. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of the at least one immune response component by directing the formation of one or more chimeric antibodies associated with the one or more determinants of the agent operable for modulating at least a part of the immune response.
-
110. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of the at least one immune response component by directing the formation of one or more recombinant antibodies associated with the one or more determinants of the agent operable for modulating at least a part of the immune response.
-
111. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of the at least one immune response component by including data from databases for influencing the identification of the one or more determinants of the agent.
-
112. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of the at least one immune response component by including data from genomic, immunological, biological, or SNP databases for influencing the identification of at least one determinant of the agent.
-
113. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of the at least one immune response component by including data from a pathogen database.
-
114. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for designating the selection of the at least one immune response component by including data from a human database.
-
115. The system of claim 62, wherein the circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent further comprises:
circuitry for aiding the selection of the at least one immune response component by providing a plan.
-
116. The system of claim 115, wherein the circuitry for aiding the selection of the at least one immune response component by providing a plan further comprises:
circuitry for providing the plan for managing at least a part of the immune response.
-
117. The system of claim 115, wherein the plan further comprises:
at least one of a dosage, a dosing pattern, an effective route, or duration of a dosage.
-
118. The system of claim 117, wherein the effective route comprises:
at least one of a sub-cutaneous route, a nasal route, an intranasal route, an intramuscular route, an intravenous route, an intraarterial route, an intrathecal route, an intracapsular route, an intraorbital route, an intracardiac route, a transdermal route, an intradermal route, an intraperitoneal route, a transtracheal route, a subcuticular route, an intraarticular route, a subcapsular route, a subarachnoidal route, an intraspinal route, an epidural route, an intrasternal route, an infusion route, a topical route, a sublingual route, or an enteric route.
-
119. The system of claim 62, wherein the circuitry for presenting one or more determinants of an agent further comprises:
circuitry for presenting one or more determinants associated with a response and wherein the response requires management.
-
120. The system of claim 62, wherein the circuitry for presenting one or more determinants of an agent further comprises:
circuitry for presenting at least a portion of at least one of a virus, a bacterium, a yeast, a mold, a fungus, a mycoplasma, a ureaplasma, a Chlamydia, a rickettsia, a nanobacterium, a prion, an agent responsible for TSE, a multicellular parasite, a protein, an infectious protein, a nucleic acid, a metabolic by-product, a cellular by-product, or a toxin.
-
121. The system of claim 62, wherein the agent includes:
at least a portion of a living agent.
-
122. The system of claim 62, wherein the agent includes:
at least a portion of a non-living agent.
-
63. The system of claim 62, wherein the circuitry for presenting one or more determinants of an agent further comprises:
-
-
123. A system, comprising:
a computer readable medium including, but not limited to, a computer program for use with a computer system and wherein the computer program includes a plurality of instructions including;
one or more instructions for presenting one or more determinants of an agent;
one or more instructions for providing a predicted pattern for a progression related to the one or more determinants of the agent; and
one or more instructions for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent.
-
124. A program product, comprising:
at least one signal bearing medium including means for presenting one or more determinants of an agent;
means for providing a predicted pattern for a progression related to the one or more determinants of the agent; and
means for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent. - View Dependent Claims (125)
-
125. The system of claim 124, wherein the at least one signal bearing medium further comprises:
at least one of a recordable medium or a transmission medium.
-
125. The system of claim 124, wherein the at least one signal bearing medium further comprises:
-
126. A method of related to an immune response, comprising:
-
specifying an agent; and
presenting one or more determinants of the specified agent.
-
-
127. A system related to an immune response, comprising:
-
circuitry for specifying an agent; and
circuitry for presenting one or more determinants of the specified agent.
-
-
128. A method related to an immune response, comprising:
-
providing a predicted pattern for a progression related to one or more determinants of an agent; and
designating the selection of at least one immune response component corresponding to the one or more determinants of the agent.
-
-
129. A system related to an immune response, comprising:
-
circuitry for providing a predicted pattern for a progression related to one or more determinants of an agent; and
circuitry for designating the selection of at least one immune response component corresponding to the one or more determinants of the agent.
-
Specification
- Resources
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeSearete LLC (Intellectual Ventures LLC)
-
Original AssigneeSearete LLC (Intellectual Ventures LLC)
-
InventorsIshikawa, Muriel Y., Myhrvold, Nathan P., Wood, Lowell L. Jr., Jung, Edward K.Y., Wilson, Richa
-
Application NumberUS10/925,902Publication NumberTime in Patent OfficeDaysField of SearchUS Class Current702/19CPC Class CodesA61K 39/00 Medicinal preparations cont...Y02A 50/30 Against vector-borne diseas...